Cargando…

Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population

Low homoarginine is an independent marker of mortality in heart failure patients and incident cardiovascular events. Whether homoarginine is related with healthier cardiac structure and function is currently unclear. We used data of the population-based “Study of Health in Pomerania” (SHIP-Trend) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahls, Martin, Atzler, Dorothee, Markus, Marcello R.P., Friedrich, Nele, Böger, Rainer H., Völzke, Henry, Felix, Stephan B., Schwedhelm, Edzard, Dörr, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165018/
https://www.ncbi.nlm.nih.gov/pubmed/30061520
http://dx.doi.org/10.3390/biom8030063
_version_ 1783359737940672512
author Bahls, Martin
Atzler, Dorothee
Markus, Marcello R.P.
Friedrich, Nele
Böger, Rainer H.
Völzke, Henry
Felix, Stephan B.
Schwedhelm, Edzard
Dörr, Marcus
author_facet Bahls, Martin
Atzler, Dorothee
Markus, Marcello R.P.
Friedrich, Nele
Böger, Rainer H.
Völzke, Henry
Felix, Stephan B.
Schwedhelm, Edzard
Dörr, Marcus
author_sort Bahls, Martin
collection PubMed
description Low homoarginine is an independent marker of mortality in heart failure patients and incident cardiovascular events. Whether homoarginine is related with healthier cardiac structure and function is currently unclear. We used data of the population-based “Study of Health in Pomerania” (SHIP-Trend) to assess this relation. Homoarginine was measured in serum using liquid chromatography-tandem mass spectrometry. Linear regression models assessed the relation between homoarginine and several structural as well as functional parameters and N-terminal pro B-type natriuretic peptide (NTproBNP). All models were adjusted for age, sex, body mass index, and renal function. A total of 3113 subjects (median age 48 (25th percentile 37 to 75th percentile 60) years, 46% male) were included. A standard deviation decrease in homoarginine was associated with a larger left ventricular diastolic diameter (0.3; 95%-confidence interval (CI): 0.2 to 0.5 mm; p < 0.001), left ventricular systolic diameter (0.38; 95%-CI: −0.22 to 0.54 mm; p < 0.001) as well as a less relative wall thickness (–0.003 95%-CI: −0.006 to −0.0008; p = 0.01), left ventricular ejection fraction (–0.47; 95%-CI: –0.79 to −0.15%; p < 0.01) and fractional shortening (−0.35; 95%-CI: −0.62 to 0.07%; p = 0.01). Low homoarginine was also related to higher NTproBNP (−0.02 95%-CI: −0.034 to −0.009 log pg/mL; p < 0.01). Lower serum homoarginine is associated with dilatation of the heart and decreased function. Prospective clinical studies should assess if homoarginine supplementation improves cardiac health in subjects with low serum concentrations.
format Online
Article
Text
id pubmed-6165018
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61650182018-10-10 Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population Bahls, Martin Atzler, Dorothee Markus, Marcello R.P. Friedrich, Nele Böger, Rainer H. Völzke, Henry Felix, Stephan B. Schwedhelm, Edzard Dörr, Marcus Biomolecules Article Low homoarginine is an independent marker of mortality in heart failure patients and incident cardiovascular events. Whether homoarginine is related with healthier cardiac structure and function is currently unclear. We used data of the population-based “Study of Health in Pomerania” (SHIP-Trend) to assess this relation. Homoarginine was measured in serum using liquid chromatography-tandem mass spectrometry. Linear regression models assessed the relation between homoarginine and several structural as well as functional parameters and N-terminal pro B-type natriuretic peptide (NTproBNP). All models were adjusted for age, sex, body mass index, and renal function. A total of 3113 subjects (median age 48 (25th percentile 37 to 75th percentile 60) years, 46% male) were included. A standard deviation decrease in homoarginine was associated with a larger left ventricular diastolic diameter (0.3; 95%-confidence interval (CI): 0.2 to 0.5 mm; p < 0.001), left ventricular systolic diameter (0.38; 95%-CI: −0.22 to 0.54 mm; p < 0.001) as well as a less relative wall thickness (–0.003 95%-CI: −0.006 to −0.0008; p = 0.01), left ventricular ejection fraction (–0.47; 95%-CI: –0.79 to −0.15%; p < 0.01) and fractional shortening (−0.35; 95%-CI: −0.62 to 0.07%; p = 0.01). Low homoarginine was also related to higher NTproBNP (−0.02 95%-CI: −0.034 to −0.009 log pg/mL; p < 0.01). Lower serum homoarginine is associated with dilatation of the heart and decreased function. Prospective clinical studies should assess if homoarginine supplementation improves cardiac health in subjects with low serum concentrations. MDPI 2018-07-30 /pmc/articles/PMC6165018/ /pubmed/30061520 http://dx.doi.org/10.3390/biom8030063 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bahls, Martin
Atzler, Dorothee
Markus, Marcello R.P.
Friedrich, Nele
Böger, Rainer H.
Völzke, Henry
Felix, Stephan B.
Schwedhelm, Edzard
Dörr, Marcus
Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title_full Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title_fullStr Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title_full_unstemmed Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title_short Low-Circulating Homoarginine is Associated with Dilatation and Decreased Function of the Left Ventricle in the General Population
title_sort low-circulating homoarginine is associated with dilatation and decreased function of the left ventricle in the general population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165018/
https://www.ncbi.nlm.nih.gov/pubmed/30061520
http://dx.doi.org/10.3390/biom8030063
work_keys_str_mv AT bahlsmartin lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT atzlerdorothee lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT markusmarcellorp lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT friedrichnele lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT bogerrainerh lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT volzkehenry lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT felixstephanb lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT schwedhelmedzard lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation
AT dorrmarcus lowcirculatinghomoarginineisassociatedwithdilatationanddecreasedfunctionoftheleftventricleinthegeneralpopulation